{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:57:19Z","timestamp":1769947039779,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer New York","isbn-type":[{"value":"9781493940097","type":"print"},{"value":"9781493940110","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-4011-0_9","type":"book-chapter","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:40:51Z","timestamp":1472604051000},"page":"95-109","source":"Crossref","is-referenced-by-count":11,"title":["Detecting Autophagy and Autophagy Flux in Chronic Myeloid Leukemia Cells Using a Cyto-ID Fluorescence Spectrophotometric Assay"],"prefix":"10.1007","author":[{"given":"Sujuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Pridham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460\u2013473","journal-title":"Antioxid Redox Signal"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI78652","volume":"125","author":"G Kroemer","year":"2015","unstructured":"Kroemer G (2015) Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest 125:1\u20134","journal-title":"J Clin Invest"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cr.2013.161","volume":"24","author":"P Jiang","year":"2014","unstructured":"Jiang P, Mizushima N (2014) Autophagy and human diseases. Cell Res 24:69\u201379","journal-title":"Cell Res"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","volume":"157","author":"DR Green","year":"2014","unstructured":"Green DR, Levine B (2014) To be or not to be? How selective autophagy and cell death govern cell fate. Cell 157:65\u201375","journal-title":"Cell"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AM Choi","year":"2013","unstructured":"Choi AM, Ryter SW, Levine B (2013) Autophagy in human health and disease. N Engl J Med 368:651\u2013662","journal-title":"N Engl J Med"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gde.2010.12.008","volume":"21","author":"R Mathew","year":"2011","unstructured":"Mathew R, White E (2011) Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 21:113\u2013119","journal-title":"Curr Opin Genet Dev"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","volume":"11","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11:709\u2013730","journal-title":"Nat Rev Drug Discov"},{"key":"9_CR8","first-page":"85","volume":"25","author":"PCHD Nowell","year":"1960","unstructured":"Nowell PCHD (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25:85\u2013109","journal-title":"J Natl Cancer Inst"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290\u2013293","journal-title":"Nature"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550\u2013554","journal-title":"Nature"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"CR Bartram","year":"1983","unstructured":"Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D et al (1983) Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306:277\u2013280","journal-title":"Nature"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93\u201399","journal-title":"Cell"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s13238-013-2115-0","volume":"4","author":"H Zhang","year":"2013","unstructured":"Zhang H, Li S (2013) Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells. Protein Cell 4:186\u2013196","journal-title":"Protein Cell"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","volume":"169","author":"A Sinclair","year":"2013","unstructured":"Sinclair A, Latif AL, Holyoake TL (2013) Targeting survival pathways in chronic myeloid leukaemia stem cells. Br J Pharmacol 169:1693\u2013707","journal-title":"Br J Pharmacol"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561\u2013566","journal-title":"Nat Med"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","volume":"4","author":"H Quentmeier","year":"2011","unstructured":"Quentmeier H, Eberth S, Romani J, Zaborski M, Drexler HG (2011) BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance. J Hematol Oncol 4:6","journal-title":"J Hematol Oncol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4161\/auto.6.7.13067","volume":"6","author":"E Vakana","year":"2010","unstructured":"Vakana E, Sassano A, Platanias LC (2010) Induction of autophagy by dual mTORC1-mTORC2 inhibition in BCR-ABL-expressing leukemic cells. Autophagy 6:966\u2013967","journal-title":"Autophagy"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MOH.0b013e3283366bcb","volume":"17","author":"M Osborn","year":"2010","unstructured":"Osborn M, Hughes T (2010) Managing imatinib resistance in chronic myeloid leukaemia. Curr Opin Hematol 17:97\u2013103","journal-title":"Curr Opin Hematol"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","volume":"274","author":"G Volpe","year":"2009","unstructured":"Volpe G, Panuzzo C, Ulisciani S, Cilloni D (2009) Imatinib resistance in CML. Cancer Lett 274:1\u20139","journal-title":"Cancer Lett"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","volume":"118","author":"Z Sheng","year":"2011","unstructured":"Sheng Z, Ma L, Sun JE, Zhu LJ, Green MR (2011) BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription. Blood 118:2840\u20132848","journal-title":"Blood"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20101145","volume":"208","author":"M Mortensen","year":"2011","unstructured":"Mortensen M, Soilleux EJ, Djordjevic G, Tripp R, Lutteropp M, Sadighi-Akha E, Stranks AJ, Glanville J, Knight S, Jacobsen SE, Kranc KR, Simon AK (2011) The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 208:455\u2013467","journal-title":"J Exp Med"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","volume":"118","author":"GV Helgason","year":"2011","unstructured":"Helgason GV, Karvela M, Holyoake TL (2011) Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 118:2035\u20132043","journal-title":"Blood"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2011-07-366153","volume":"118","author":"NJ Donato","year":"2011","unstructured":"Donato NJ (2011) Bcr-Abl adds another twist to cell fate. Blood 118:2646\u20132647","journal-title":"Blood"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.21914","volume":"86","author":"LC Crowley","year":"2011","unstructured":"Crowley LC, Elzinga BM, O\u2019Sullivan GC, McKenna SL (2011) Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol 86:38\u201347","journal-title":"Am J Hematol"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/onc.2010.561","volume":"30","author":"BJ Altman","year":"2011","unstructured":"Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL, Ilkayeva O, Jia W, He YW, Rathmell JC (2011) Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 30:1855\u20131867","journal-title":"Oncogene"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4161\/cc.9.17.13048","volume":"9","author":"A Puissant","year":"2010","unstructured":"Puissant A, Robert G, Auberger P (2010) Targeting autophagy to fight hematopoietic malignancies. Cell Cycle 9:3470\u20133478","journal-title":"Cell Cycle"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/auto.5.7.9509","volume":"5","author":"P Salomoni","year":"2009","unstructured":"Salomoni P, Calabretta B (2009) Targeted therapies and autophagy: new insights from chronic myeloid leukemia. Autophagy 5:1050\u20131051","journal-title":"Autophagy"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","volume":"119","author":"C Bellodi","year":"2009","unstructured":"Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, Van Etten RA, Donato N, Hunter A, Dinsdale D, Tirr\u00f2 E, Vigneri P, Nicotera P, Dyer MJ, Holyoake T, Salomoni P, Calabretta B (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119:1109\u20131123","journal-title":"J Clin Invest"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/15548627.2015.1017181","volume":"11","author":"S Guo","year":"2015","unstructured":"Guo S, Liang Y, Murphy SF, Huang A, Shen H, Kelly DF, Sobrado P, Sheng Z (2015) A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy 11:560\u2013572","journal-title":"Autophagy"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/auto.21028","volume":"8","author":"LL Chan","year":"2012","unstructured":"Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, Chan E, Kuksin D, Lin B, Qiu J (2012) A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8:1371\u20131382","journal-title":"Autophagy"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445\u2013544","journal-title":"Autophagy"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140:313\u2013326","journal-title":"Cell"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCRESAHA.116.303787","volume":"116","author":"RA Gottlieb","year":"2015","unstructured":"Gottlieb RA, Andres AM, Sin J, Taylor DP (2015) Untangling autophagy measurements: all fluxed up. Circ Res 116:504\u2013514","journal-title":"Circ Res"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0040-8166(81)90013-6","volume":"13","author":"JJ Trout","year":"1981","unstructured":"Trout JJ, Stauber WT, Schottelius BA (1981) Increased autophagy in chloroquine-treated tonic and phasic muscles: an alternative view. Tissue Cell 13:393\u2013401","journal-title":"Tissue Cell"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/emboj.2009.35","volume":"28","author":"Z Sheng","year":"2009","unstructured":"Sheng Z, Wang SZ, Green MR (2009) Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R. Embo J 28:866\u2013876","journal-title":"Embo J"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm.2158","volume":"16","author":"Z Sheng","year":"2010","unstructured":"Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR (2010) A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med 16:671\u2013677","journal-title":"Nat Med"}],"container-title":["Methods in Molecular Biology","Chronic Myeloid Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-4011-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:41:41Z","timestamp":1498326101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-4011-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493940097","9781493940110"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-4011-0_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}